SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-22-035691
Filing Date
2022-03-18
Accepted
2022-03-18 17:22:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm229544d2_424b5.htm 424B5 8701
2 GRAPHIC tm229544d2_424b5img001.jpg GRAPHIC 29673
  Complete submission text file 0001104659-22-035691.txt   51001
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-258687 | Film No.: 22753515
SIC: 2834 Pharmaceutical Preparations